Coegin Pharma AB (NGM: COEGIN)

Coegin Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.77	5.55	3.82	25.66	16.65
Cash & Short-Term Investments	13.77	5.55	3.82	25.66	16.65
Cash Growth	26.66%	45.39%	-85.13%	54.12%	-
Other Receivables	0.79	0.64	3.13	4.64	2.5
Receivables	0.79	0.64	3.13	4.64	2.5
Prepaid Expenses	0.21	0.02	0.02	0.03	-
Total Current Assets	14.77	6.21	6.97	30.33	19.14
Property, Plant & Equipment	0.23	0.3	0.49	0	0
Other Intangible Assets	7.49	8.92	11.79	-	-
Other Long-Term Assets	-	-	10	-	-
Total Assets	22.48	15.43	29.25	30.34	19.15
Accounts Payable	0.2	1.79	2	9.73	1.77
Accrued Expenses	0.58	2.66	1.71	0.22	-
Current Income Taxes Payable	-	-	0.18	-	-
Other Current Liabilities	0.12	4.24	4.34	0.31	0.66
Total Current Liabilities	0.89	8.68	8.23	10.26	2.43
Total Liabilities	0.89	8.68	8.23	10.26	2.43
Common Stock	10.19	4.7	35.33	27.57	23.11
Additional Paid-In Capital	121.99	101.6	94.76	66.38	41.5
Retained Earnings	-	-	-	-75.07	-47.93
Comprehensive Income & Other	-110.59	-99.54	-109.08	1.2	0.04
Shareholders' Equity	21.59	6.75	21.01	20.07	16.71
Total Liabilities & Equity	22.48	15.43	29.25	30.34	19.15
Net Cash (Debt)	13.77	5.55	3.82	25.66	16.65
Net Cash Growth	26.66%	45.39%	-85.13%	54.12%	-
Net Cash Per Share	1.11	0.60	0.56	4.32	12.74
Filing Date Shares Outstanding	20.39	9.39	6.94	6.94	1.31
Total Common Shares Outstanding	20.39	9.39	6.94	6.94	1.31
Working Capital	13.88	-2.47	-1.26	20.07	16.71
Book Value Per Share	1.06	0.72	3.03	2.89	12.79
Tangible Book Value	14.11	-2.17	9.22	20.07	16.71
Tangible Book Value Per Share	0.69	-0.23	1.33	2.89	12.79
Machinery	-	0.64	0.68	0.15	0.15

Source: S&P Capital IQ. Standard template. Financial Sources.